TY - JOUR
T1 - The complicated role of mitochondria in the podocyte
AU - Gujarati, Nehaben A.
AU - Vasquez, Jessica M.
AU - Bogenhagen, Daniel F.
AU - Mallipattu, Sandeep K.
N1 - Publisher Copyright:
© 2020 American Physiological Society. All rights reserved.
PY - 2020/12
Y1 - 2020/12
N2 - Mitochondria play a complex role in maintaining cellular function including ATP generation, generation of biosynthetic precursors for macromolecules, maintenance of redox homeostasis, and metabolic waste management. Although the contribution of mitochondrial function in various kidney diseases has been studied, there are still avenues that need to be explored under healthy and diseased conditions. Mitochondrial damage and dysfunction have been implicated in experimental models of podocytopathy as well as in humans with glomerular diseases resulting from podocyte dysfunction. Specifically, in the podocyte, metabolism is largely driven by oxidative phosphorylation or glycolysis depending on the metabolic needs. These metabolic needs may change drastically in the presence of podocyte injury in glomerular diseases such as diabetic kidney disease or focal segmental glomerulosclerosis. Here, we review the role of mitochondria in the podocyte and the factors regulating its function at baseline and in a variety of podocytopathies to identify potential targets for therapy.
AB - Mitochondria play a complex role in maintaining cellular function including ATP generation, generation of biosynthetic precursors for macromolecules, maintenance of redox homeostasis, and metabolic waste management. Although the contribution of mitochondrial function in various kidney diseases has been studied, there are still avenues that need to be explored under healthy and diseased conditions. Mitochondrial damage and dysfunction have been implicated in experimental models of podocytopathy as well as in humans with glomerular diseases resulting from podocyte dysfunction. Specifically, in the podocyte, metabolism is largely driven by oxidative phosphorylation or glycolysis depending on the metabolic needs. These metabolic needs may change drastically in the presence of podocyte injury in glomerular diseases such as diabetic kidney disease or focal segmental glomerulosclerosis. Here, we review the role of mitochondria in the podocyte and the factors regulating its function at baseline and in a variety of podocytopathies to identify potential targets for therapy.
KW - Glomerulosclerosis
KW - Kidney disease
KW - Mitochondria
KW - Podocytes
KW - Proteinuria
UR - http://www.scopus.com/inward/record.url?scp=85096508348&partnerID=8YFLogxK
U2 - 10.1152/AJPRENAL.00393.2020
DO - 10.1152/AJPRENAL.00393.2020
M3 - Review article
C2 - 33073585
AN - SCOPUS:85096508348
SN - 1931-857X
VL - 319
SP - F955-F965
JO - American Journal of Physiology - Renal Physiology
JF - American Journal of Physiology - Renal Physiology
IS - 6
ER -